These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28708445)

  • 21. [Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].
    Liu D; Ma X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(4):238-42, 245. PubMed ID: 24800539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pars flaccida displacement pattern in purulent otitis media in the gerbil.
    Larsson C; Dirckx JJ; Decraemer WF; Bagger-Sjöbäck D; von Unge M
    Otol Neurotol; 2003 May; 24(3):358-64. PubMed ID: 12806284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progress in middle ear dysventilation research].
    Yang Q; Zhao Y; Wang ZY; Yu YJ; Zhang W; Wang WQ; Hou ZH; Chen Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):303-306. PubMed ID: 30991784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contralateral ear in cholesteatoma.
    da Costa SS; Teixeira AR; Rosito LP
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1717-21. PubMed ID: 26223352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The peculiar clinical features of different types of acquired cholesteatoma of the middle ear].
    Anikin IA; Bokuchava TA
    Vestn Otorinolaringol; 2018; 83(3):11-15. PubMed ID: 29953047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathogenesis of acquired cholesteatoma of the human middle ear: support for the migration hypothesis.
    Karmody CS; Northrop C
    Otol Neurotol; 2012 Jan; 33(1):42-7. PubMed ID: 22143292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric tympanic membrane cholesteatoma: Systematic review and meta-analysis.
    Ching HH; Spinner AG; Ng M
    Int J Pediatr Otorhinolaryngol; 2017 Nov; 102():21-27. PubMed ID: 29106870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tympanic membrane displacement patterns in experimental cholesteatoma.
    von Unge M; Decraemer WF; Dirckx JJ; Bagger-Sjöbäck D
    Hear Res; 1999 Feb; 128(1-2):1-15. PubMed ID: 10082278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic analysis of cell proliferation using bromodeoxyuridine labeling and in situ detection of dying cells in the tympanic membrane and middle ear cholesteatoma.
    Koba R; Yagi M; Tabe H; Kawabata I
    Arch Histol Cytol; 1996 Oct; 59(4):339-46. PubMed ID: 8937634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The expression of Ras protein in human middle ear cholesteatoma].
    Xu Y; Jin K; Dong W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical findings and surgical results of middle ear cholesteatoma behind an intact tympanic membrane in adults.
    Di Lella F; Bacciu A; Pasanisi E; Ruberto M; D'Angelo G; Vincenti V
    Acta Biomed; 2016 May; 87(1):64-9. PubMed ID: 27163897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tympanic membrane changes in experimental cholesteatoma in the gerbil.
    Larsson C; von Unge M; Bagger-Sjöbäck D
    Am J Otol; 1999 May; 20(3):309-16. PubMed ID: 10337970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical significance of the tympanic isthmus related to the development of cholesteatoma.
    Miyajima I; Honda Y
    Auris Nasus Larynx; 1985; 12(3):149-55. PubMed ID: 3834893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo over-expression of KGF mimic human middle ear cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Shibata Y; Takahashi H; Ikeda T; Koji T
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2689-96. PubMed ID: 25138153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression pattern of the plasminogen activator-plasmin system in human cholesteatoma.
    Schönermark MP; Issing PR; Erbrich BK; Lenarz T
    Ann Otol Rhinol Laryngol; 1999 Mar; 108(3):245-52. PubMed ID: 10086616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Middle ear cholesteatoma with sinus thrombosis in central perforation of the tympanic membrane].
    BRAUN-FALCO F
    HNO; 1960 May; 8():251-2. PubMed ID: 13804007
    [No Abstract]   [Full Text] [Related]  

  • 37. Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth.
    Ho KY; Yeh TS; Huang HH; Hung KF; Chai CY; Chen WT; Tsai SM; Chang NC; Chien CY; Wang HM; Wu YJ
    Int J Mol Sci; 2013 Jul; 14(7):14439-59. PubMed ID: 23852020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
    Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
    Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new theory on the pathogenesis of acquired cholesteatoma: Mucosal traction.
    Jackler RK; Santa Maria PL; Varsak YK; Nguyen A; Blevins NH
    Laryngoscope; 2015 Aug; 125 Suppl 4():S1-S14. PubMed ID: 26013635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.